And only a fraction of patients have their hypertension well-controlled, meaning there’s a need for novel strategies. The ...

Needham raised the firm’s price target on Rush Street Interactive (RSI) to $17 from $15 and keeps a Buy rating on the shares ...

Needham lowered the firm’s price target on RxSight (RXST) to $43 from $66 and keeps a Buy rating on the shares as part of a ...

Valley, the MSTCA Division 1 relays took place at the Reggie Lewis Center and the Gatorade Girls' Cross-Country Runner of the Year was unveiled.

Eric Swayze, Executive Vice President of Research at Ionis Pharmaceuticals Inc. (NASDAQ:IONS), a $5 billion market cap ...

Brett Monia, Chief Executive Officer of Ionis Pharmaceuticals Inc. (NASDAQ:IONS), recently sold a significant portion of his ...